AUG 13, 2015 10:25 AM PDT

Beating Obesity

You might have been told that cannabis makes you hungry. A team of researchers is finding a way to use it in a weight loss pill. Why is that so important?



Researchers test zebrafish and human cells to test the cannabis-vitamin A combination they want to use as a weight loss drug.



According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than two-thirds (68.8 percent) of adults are considered to be overweight or obese. Additionally, more than one-third (35.7 percent) of adults are considered to be obese, more than 1 in 20 (6.3 percent) are extremely obese, nearly 3 in 4 men (74 percent) are considered to be overweight or obese and 8 percent of women are considered to be extremely obese. The prevalence of obesity is similar for both men and women (about 36 percent (https://www.niddk.nih.gov/health-information/health-statistics/Pages/overweight-obesity-statistics.aspx).



Medical researchers, who are part of Deakin University Medical School’s Metabolic Research Unit have taken the unusual approach of combining two pharmaceuticals – extracted from cannabis and vitamin A – with the eventual aim of developing a drug to treat obesity. They “used zebrafish and human cells to test the effect of the Endocannabinoid system (an active compound of cannabis which plays a role in appetite regulation and fat formation) and the Retinoic Acid Pathway (an active component of vitamin A) on reducing the deposit of fat,” according to an article in Drug Discovery & Development (https://www.dddmag.com/news/2015/08/medical-researchers-step-closer-developing-anti-obesity-pill?et_cid=4738815&et_rid=45505806&location=top).



As explained by Dr Yann Gibert, the Head of the Metabolic Genetic Diseases Research Laboratory, "The results of our study show, for the first time, that particular compounds in cannabis and vitamin A can work together to reduce the deposit of lipids (fats). This finding opens up exciting opportunities to potentially treat obesity without the need for invasive surgery."



He added, "The complementary actions of the Endocannabinoid system and Retinoic Acid Pathway in reducing fat deposits have the potential to treat obesity in a safer and more effective way than if they were used independently. This approach only focuses on fat, and avoids effects on the brain, which has been a concern in previous research involving cannabis."



While it is understood that the cannabis system regulates appetite, adverse side effects have kept researchers from using drug in humans for medical purposes. Dr. Gilbert’ss research has discovered a method of potentially removing these negative effects by using the two systems together and at a reduced dosage. Inasmuch as this study has shown that these two pathways can work together during fat accumulation, the method of doing so is not clear.

Dr Gibert stated that the team is planning to test the effectiveness of the drug further and to determine whether there are side effects. He concluded, "If there are no side effects, new therapeutics could be ready for human use within five years."

About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
The Use of Cannabis in Treating Fibromyalgia
It has been found that 90% of patients that are diagnosed with fibromyalgia are women, and only a decade ago doctors thought this condition wasn't real...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Scientists Produce Electricity From Marijuana Metabolites
In a recent study, scientists were able to successfully turn cannabis metabolites into electricity. The paper, published by Dr. Tunc Canal and co...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
More Evidence That High-Potency Pot is Linked to Psychosis
The debate around the link between marijuana and psychosis continues. The general consensus up to this point acknowledged a possible risk, but only fo...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Cancer Patients Prefer Higher Potency Medical Marijuana, Study Finds
A recent study published in the Journal of Palliative Medicine by Dr. Arum Kim, MD, and colleagues, from the New York University School of Medicine suggest...
SEP 19, 2019
Health & Medicine
SEP 19, 2019
Is Marijuana Harmful to Pets?
Dorrie Black works at Animal Internal Medicine and Specialty Services, a 24-hour veterinary clinic near Golden Gate Park in San Francisco. She says she oft...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Use of Cannabis, Alcohol and Tobacco: What Do Online Search Records Reveal?
A new study found cannabis legalization affected searches for alcohol and tobacco differently...
Loading Comments...